CSIMarket
 
Resmed Inc   (NYSE: RMD)
Other Ticker:  
 
 
Price: $224.1600 $4.44 2.021%
Day's High: $224.64 Week Perf: -5.27 %
Day's Low: $ 219.19 30 Day Perf: -5.26 %
Volume (M): 747 52 Wk High: $ 263.05
Volume (M$): $ 167,425 52 Wk Avg: $224.38
Open: $219.89 52 Wk Low: $172.19



 Market Capitalization (Millions $) 33,086
 Shares Outstanding (Millions) 148
 Employees 9,980
 Revenues (TTM) (Millions $) 4,775
 Net Income (TTM) (Millions $) 1,113
 Cash Flow (TTM) (Millions $) 217
 Capital Exp. (TTM) (Millions $) 94

Resmed Inc
Company Profile: ResMed Inc.

Overview:
ResMed Inc. is a global leader in the development, manufacturing, and distribution of innovative products and solutions for sleep apnea and other respiratory conditions. Established in 1989 in Sydney, Australia, ResMed has evolved into a multinational corporation with a presence in over 140 countries.

Products and Solutions:
ResMed specializes in designing and producing high-quality medical devices, primarily focused on treating sleep disorders such as obstructive sleep apnea. Key products include:

- Continuous Positive Airway Pressure (CPAP) Machines: Devices that provide air pressure to keep the airways open during sleep.
- Masks and Accessories: A range of masks designed for comfort and effectiveness, complemented by essential accessories.
- Digital Health Technologies: Cloud-based software solutions that enable healthcare providers to remotely monitor and manage patient conditions.

ResMed's proprietary technology is anchored in advanced ventilation algorithms that utilize sensors and data analytics. This technology customizes treatment plans based on individual patient needs, automatically adjusting air pressure to ensure precise treatment throughout the night, ultimately leading to better sleep and enhanced health outcomes.

Research and Development:
The company is devoted to advancing the field of respiratory medicine through substantial investments in research and development. ResMed conducts clinical studies and collaborates with leading healthcare providers and research institutions globally. Additionally, the company works with patient advocacy groups to enhance awareness of sleep disorders, promote patient education, and encourage adherence to treatment protocols.

Headquarters and Global Presence:
ResMeds corporate headquarters are located in San Diego, California. It operates additional facilities throughout Australia, Europe, and the Asia-Pacific region, allowing for comprehensive support and distribution of its products internationally.

Recognition and Performance:
ResMed has garnered accolades for product innovation, sustainability initiatives, and corporate social responsibility. The company is publicly traded on major stock exchanges, including the New York Stock Exchange (NYSE) and the Australian Securities Exchange (ASX).

Conclusion:
Through its commitment to innovation, patient-centric solutions, and global reach, ResMed Inc. continues to impact the field of respiratory health, improving the lives of patients suffering from sleep disorders and contributing to advancements in respiratory medicine.


   Company Address: 9001 Spectrum Center Blvd. San Diego 92123 CA
   Company Phone Number: 836-5000   Stock Exchange / Ticker: NYSE RMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -5.39%    
BDX   -0.65%    
ICUI        10.3% 
INGN        0.4% 
INSP   -9.59%    
MASI        1.67% 
• View Complete Report
   



Resmed Inc

ResMed Inc. Delivers Remarkable Revenue Growth in Q1 2025 Amid Industry Challenges

ResMed's Impressive Q1 2025 Results: A Beacon in the Medical Equipment SectorIn a remarkable illustration of resilience, ResMed Inc. (NYSE: RMD, ASX: RMD) has announced its financial first quarter results for fiscal year 2025, showcasing a significant leap in profitability and an upward trajectory in revenue. As many companies in the Medical Equipment & Supplies industry grapple with challenges such as diminishing transactions and declining revenue, ResMed's robust performance stands out as a beacon of hope and efficacy within this competitive landscape. Stellar Financial PerformanceFor the first quarter ending September 30, 2024, ResMed reported a staggering 41.61% increase in earnings per share, climbing to $2.11 compared to the same period last year. This surge underscores the company's effective strategies and operational efficiencies, allowing it to thrive even when others falter.

Management Announcement

ResMeds Forward-Thinking 2030 Strategy: A Robust Blueprint for Sustainable Growth and Shareholder Value

Published Mon, Sep 30 2024 8:05 PM UTC

In a significant move aimed at securing its position as a leader in the healthcare sector, ResMed (NYSE: RMD, ASX: RMD) unveiled its ambitious 2030 Strategy during an Investor Day event held in New York City on September 30, 2024. This new initiative is designed to drive growth, enhance profitability, and maximize shareholder returns, reflecting ResMed s commitment to innova...

Product Service News

ResMed Introduces Innovative Fabric CPAP Mask for Improved Sleep Health

Published Mon, Sep 30 2024 12:11 PM UTC

In a significant development for sleep apnea treatment, ResMed Inc. (NYSE: RMD) has launched its first-ever fabric CPAP mask, a product that promises to enhance comfort and usability for individuals undergoing Continuous Positive Airway Pressure (CPAP) therapy. This innovative design aims to make it easier for patients to adhere to their prescribed treatment and, in turn, im...

Resmed Inc

Resmed Inc. Reports Impressive Fourth Quarter 2024 Results Marked by Significant Revenue Growth and Earnings Surge

Resmed Inc, a global leader in the medical equipment and supplies industry, has reported strong financial results for the April to June 2024 period. The company achieved a 26.77% increase in earnings per share (EPS), reaching $1.98 compared to the prior year quarter. Additionally, Resmed Inc experienced a revenue growth of 9.329%, generating $1.22 billion in revenue, up from $1.11 billion in the same quarter of the previous year.
Compared to its peers in the Medical Equipment & Supplies industry, Resmed Inc's revenue improvement in the fourth quarter of 2024 outperformed the industry's overall business rise of 1.07% during the same period. This highlights Resmed Inc's strong performance and competitive advantage within its industry.

Dividend

ResMed Inc. Reports Fourth Quarter Earnings Amidst Optimism Over Dividend Outlook

Published Thu, Aug 1 2024 8:05 PM UTC


On insert date of release, ResMed Inc. announced its financial results for the fourth quarter of fiscal year 2024, revealing a solid performance that reinforces the company s position in the healthcare sector. The webcast of ResMed?s conference call, where additional details and insights were discussed, is available for those interested at http://investor.resmed.com(htt...







Resmed Inc's Segments
Total Sleep and Breathing Health    87.79 % of total Revenue
Residential Care Software    12.89 % of total Revenue
U S Canada and Latin America    58.16 % of total Revenue
U S Canada and Latin America Devices    31.62 % of total Revenue
U S Canada and Latin America Masks and other    26.54 % of total Revenue
Combined Europe Asia and other markets    29.64 % of total Revenue
Combined Europe Asia and other markets Devices    19.84 % of total Revenue
Combined Europe Asia and other markets Masks and other    9.8 % of total Revenue
Global revenue    100.68 % of total Revenue
Global revenue Devices    51.45 % of total Revenue
Global revenue Masks and other    36.34 % of total Revenue
Global revenue Total Sleep and Breathing Health    87.79 % of total Revenue
Global revenue Residential Care Software    12.89 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com